Skip to content

Tag: Tnf alpha inhibitor

Explore our medication guides and pharmacology articles within this category.

What is the mechanism of action of Renflexis? An in-depth guide

3 min read
Overproduction of the inflammatory protein TNF-alpha drives several autoimmune diseases, including rheumatoid arthritis and inflammatory bowel diseases. **What is the mechanism of action of Renflexis?** This biological medicine works by targeting and neutralizing this key inflammatory protein to reduce inflammation.

How does the drug Remicade work? Understanding the Mechanism of Infliximab

4 min read
Remicade (infliximab) was the first anti-TNF therapy approved for Crohn's disease, revolutionizing treatment for many autoimmune conditions. **How does the drug Remicade work** is a question central to understanding this biologic's impact, which stems from its ability to target and block a key inflammatory protein to bring relief from the chronic inflammation that damages tissues.

Can Humira Cause Psoriasis? Understanding the Paradoxical Effect

4 min read
According to scientific studies, approximately 2-5% of patients treated with anti-TNF-alpha medications, including Humira, may develop a rare side effect known as paradoxical psoriasis. This phenomenon involves the appearance of new psoriatic skin lesions or the exacerbation of existing ones, despite the drug being designed to treat the underlying inflammatory condition.

What is Revellex Used For?: A Comprehensive Guide to its Therapeutic Applications

4 min read
Revellex, a biologic medication containing the active ingredient infliximab, is used to treat a range of chronic inflammatory conditions, with studies showing its effectiveness across several therapeutic areas like gastroenterology, rheumatology, and dermatology. If you're questioning, "What is Revellex used for?", this guide details its approved applications, mechanism of action, and important safety considerations.

Is Humira good for Crohn's disease? Benefits, Risks, and Treatment Options

3 min read
As one of the most widely prescribed biologic medications, Humira (adalimumab) has been shown in clinical studies to significantly help many patients with moderate to severe Crohn's disease achieve remission. This article explores the benefits, risks, and overall effectiveness of Humira for managing Crohn's disease symptoms and improving long-term quality of life.